Effect of Corticosteroids in Asthma Is Not Due to Suppression of Leukotriene Release
- 7 April 1983
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 308 (14) , 846
- https://doi.org/10.1056/nejm198304073081419
Abstract
To the Editor: Although antiinflammatory corticosteroids are invaluable in the treatment of asthma, the nature of their antiasthmatic action remains obscure. Several possible biochemical mechanisms have been postulated, mainly from experiments with nonpulmonary tissues.1 More recently, experiments with guinea-pig lung have demonstrated that corticosteroids exert an inhibitory effect on phospholipase A2, an enzyme that liberates arachidonic acid from phospholipids.2 Since the leukotrienes (the biologically active moieties in slow-reacting substance of anaphylaxis [SRS-A]) are metabolites of arachidonic acid,3 the experiments presented below were performed to determine whether corticosteroids could inhibit the release of leukotrienes from human lung in . . .Keywords
This publication has 5 references indexed in Scilit:
- Effect of Benoxaprofen on Release of Slow-Reacting Substances from Human Lung Tissue In VitroClinical Science, 1982
- Selective Inhibition by Betamethasone of Allergen-Induced Release of SRS-A from Human LungInternational Archives of Allergy and Immunology, 1982
- The leukotrienes: a new group of biologically active compounds including SRS-ATrends in Pharmacological Sciences, 1980
- PHOSPHOLIPASE A2 ACTIVITY OF GUINEA‐PIG ISOLATED PERFUSED LUNGS: STIMULATION, AND INHIBITION BY ANTI‐INFLAMMATORY STEROIDSBritish Journal of Pharmacology, 1978
- INTRAVENOUS CORTICOSTEROIDS IN TREATMENT OF ACUTE BRONCHIAL ASTHMAThe Lancet, 1970